Vericel® Corporation
Biotechnology Research • 
Cambridge, Massachusetts, United States • 201-500 Employees
Company overview
| Headquarters | 64 Sidney Sreet, Cambridge, Massachusetts 02139, US |
| Phone number | +16175885555 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Clinical Trials, Clinical Research, Cell Therapy, Biologics, Automated Cell-Processing System, Multicellular Therapy Development |
| Founded | 1989 |
| Employees | 201-500 |
| Socials |
Key Contacts at Vericel® Corporation
Jeffrey Regan
Director, Market Development
Anthony Gemmellaro
Associate Director, Security, Employee Health & Safety
Brandon Gustafson
Senior Director, Commercial Excellence
Eric Christianson
Sales Director, Eastern Us
Irene Ostrovsky
Director Of Enterprise Applications And It Compliance
Robert Walker
Regional Sales Director
Parita Varma
Director Regulatory Affairs - Cmc
Mikhail Chkolnik
Associate Director Clinical Operations
James Boron
Executive Medical Director
Daniel Doyle
Associate Director, National Key Accounts
Vericel® Corporation Email Formats
Vericel® Corporation uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@vcel.com), used 73.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@vcel.com | 73.6% |
{first initial}{last name} | jdoe@vcel.com | 23.9% |
{last name}{last name} | doedoe@vcel.com | 1.4% |
About Vericel® Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. We currently market two autologous cell therapy products and one specialty biologic product in the United States. Personal integrity, teamwork, collaboration, and innovative technology are the foundations of our work. We seek to practice transparency in our clinical trials and research, and in our relationships with each other, our patients, and the investors who support us. PRIVACY AND COMMUNITY GUIDELINES When you engage with Vericel social media channels and our content providers on social media, you also agree to abide by the following Community Guidelines (found here: https://bit.ly/3pg3UKQ), which apply in addition to the Terms and Conditions or other legal notices specific to each social media channel. Please note that third-party social media channels also have access to information you share via social media. For more details, read LinkedIn's Privacy Policy here: https://bit.ly/3GF2r5Y. For additional information about privacy at Vericel, please see our Privacy Policy (bit.ly/43ErZcx) and Terms and Conditions of Use (bit.ly/4568Cdx). If you engage with us, you consent and give Vericel permission to communicate with you and to use any information, text and media associated with the interaction or post.
Vericel® Corporation revenue & valuation
| Annual revenue | $249,200,000 |
| Revenue per employee | $589,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $797,200,000 |
| Total funding | $74,800,000 |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Vericel® Corporation has 231 employees across 15 departments.
Departments
Number of employees
Vericel® Corporation Tech Stack
Discover the technologies and tools that power Vericel® Corporation's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Tag managers
Webmail
Font scripts
JavaScript libraries
UI frameworks
Analytics
CDN
Miscellaneous
Miscellaneous
Singapore
South Africa
Germany
Frequently asked questions
4.8
40,000 users
